Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
0.4007
-0.0117 (-2.84%)
At close: Jun 27, 2025, 4:00 PM
0.4045
+0.0038 (0.94%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Tilray Brands Revenue
Tilray Brands had revenue of $185.78M in the quarter ending February 28, 2025, a decrease of -1.36%. This brings the company's revenue in the last twelve months to $826.66M, up 11.22% year-over-year. In the fiscal year ending May 31, 2024, Tilray Brands had annual revenue of $788.94M with 25.80% growth.
Revenue (ttm)
$826.66M
Revenue Growth
+11.22%
P/S Ratio
0.39
Revenue / Employee
$311,946
Employees
2,650
Market Cap
400.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 788.94M | 161.82M | 25.80% |
May 31, 2023 | 627.12M | -1.25M | -0.20% |
May 31, 2022 | 628.37M | 115.29M | 22.47% |
May 31, 2021 | 513.09M | 107.76M | 26.59% |
May 31, 2020 | 405.33M | 226.02M | 126.06% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TLRY News
- 2 days ago - Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation - GlobeNewsWire
- 2 days ago - Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025 - MarijuanaStocks
- 4 days ago - Tilray Medical Receives Italy's First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use - GlobeNewsWire
- 5 days ago - Elevate Your Summer with Canada's Leading Cannabis Brands and Products by Tilray Brands - GlobeNewsWire
- 10 days ago - 3 Canadian Cannabis Stocks Traders Are Watching Closely This Week - MarijuanaStocks
- 17 days ago - Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price - GlobeNewsWire
- 17 days ago - Here's why the Tilray Brands stock has crashed, and what's next? - Invezz
- 18 days ago - Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters - GlobeNewsWire